Coverage
-
January 28, 2014
Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Co. have settled a suit against Aurobindo Pharma Ltd. over allegations that Aurobindo tried to introduce a generic version of HIV medication Sustiva before the drug's patents expire, according to a Friday filing in New Jersey federal court.
1 other articles on this case.
View all »